He X - Search Results

1

Cancer burden attributable to risk factors, 1990-2019: A comparative risk assessment.

Hu J, Dong H, Dong Y, Zhou R, Teixeira W, He X, Ye DW, Ti G. Hu J, et al. Among authors: he x. iScience. 2024 Mar 8;27(4):109430. doi: 10.1016/j.isci.2024.109430. eCollection 2024 Apr 19. iScience. 2024. PMID: 38550992 Free PMC article.

2

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials.

He XX, Ye DW. He XX, et al. Front Oncol. 2022 Jun 1;12:905654. doi: 10.3389/fonc.2022.905654. eCollection 2022. Front Oncol. 2022. PMID: 35719944 Free PMC article. No abstract available.

3

The emerging role of miR-375 in cancer.

Yan JW, Lin JS, He XX. Yan JW, et al. Int J Cancer. 2014 Sep 1;135(5):1011-8. doi: 10.1002/ijc.28563. Epub 2013 Nov 13. Int J Cancer. 2014. PMID: 24166096 Free article. Review.

4

ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway.

Ding Y, Ning Y, Kang H, Yuan Y, Lin K, Wang C, Yi Y, He J, Li L, He X, Chang Y. Ding Y, et al. Among authors: he x, he j. Exp Hematol Oncol. 2024 Jan 22;13(1):5. doi: 10.1186/s40164-024-00475-w. Exp Hematol Oncol. 2024. PMID: 38254216 Free PMC article.

5

Protein lipidation in health and disease: molecular basis, physiological function and pathological implication.

Yuan Y, Li P, Li J, Zhao Q, Chang Y, He X. Yuan Y, et al. Among authors: he x. Signal Transduct Target Ther. 2024 Mar 15;9(1):60. doi: 10.1038/s41392-024-01759-7. Signal Transduct Target Ther. 2024. PMID: 38485938 Free PMC article. Review.

6

Mouse models of liver cancer: Progress and recommendations.

He L, Tian DA, Li PY, He XX. He L, et al. Oncotarget. 2015 Sep 15;6(27):23306-22. doi: 10.18632/oncotarget.4202. Oncotarget. 2015. PMID: 26259234 Free PMC article. Review.

7

β2 spectrin-mediated differentiation repressed the properties of liver cancer stem cells through β-catenin.

Chen Y, Meng L, Shang H, Dou Q, Lu Z, Liu L, Wang Z, He X, Song Y. Chen Y, et al. Among authors: he x. Cell Death Dis. 2018 Apr 1;9(4):424. doi: 10.1038/s41419-018-0456-6. Cell Death Dis. 2018. PMID: 29555987 Free PMC article.

8

The role of YWHAZ in cancer: A maze of opportunities and challenges.

Gan Y, Ye F, He XX. Gan Y, et al. J Cancer. 2020 Feb 3;11(8):2252-2264. doi: 10.7150/jca.41316. eCollection 2020. J Cancer. 2020. PMID: 32127952 Free PMC article. Review.

9

[Molecular targeted therapy strategies for primary liver cancer].

He XX, Ren HP, Li Y, Lin JS. He XX, et al. Zhonghua Gan Zang Bing Za Zhi. 2011 Aug;19(8):561-2. doi: 10.3760/cma.j.issn.1007-3418.2011.08.001. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22152308 Chinese. No abstract available.

10

Emerging role of microRNA in hepatocellular carcinoma (Review).

Gong J, He XX, Tian A. Gong J, et al. Oncol Lett. 2015 Mar;9(3):1027-1033. doi: 10.3892/ol.2014.2816. Epub 2014 Dec 19. Oncol Lett. 2015. PMID: 25663852 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,007 results

Search Page